- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- March 2024
- 113 Pages
From €7735EUR$7,950USD£6,626GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- May 2021
- 115 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Clinical Trials
- August 2021
- 143 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Clinical Trials
- February 2021
- 137 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- May 2022
- 35 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- May 2022
- 38 Pages
Global
From €1946EUR$2,000USD£1,667GBP
Ascites Drug is a type of Gastrointestinal Drug used to treat ascites, a condition in which fluid accumulates in the abdomen. It is usually caused by liver cirrhosis, and can lead to serious complications if left untreated. Ascites Drug works by reducing the amount of fluid in the abdomen, relieving pressure on the organs and improving the patient's quality of life. Commonly used drugs include diuretics, such as furosemide and spironolactone, and albumin, a protein that helps to reduce fluid levels. Other treatments may include antibiotics, antivirals, and dietary changes.
Companies in the Ascites Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more